Swiss National Bank Sells 67,000 Shares of Zoetis Inc. $ZTS

Swiss National Bank cut its holdings in Zoetis Inc. (NYSE:ZTS) by 5.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,283,332 shares of the company’s stock after selling 67,000 shares during the quarter. Swiss National Bank owned approximately 0.29% of Zoetis worth $187,777,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ZTS. CIBC Asset Management Inc grew its holdings in shares of Zoetis by 4.3% during the 3rd quarter. CIBC Asset Management Inc now owns 251,495 shares of the company’s stock valued at $36,745,000 after purchasing an additional 10,434 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp lifted its stake in Zoetis by 6.5% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 295,482 shares of the company’s stock valued at $43,235,000 after purchasing an additional 18,040 shares during the last quarter. Ninety One UK Ltd boosted its position in Zoetis by 19.6% in the third quarter. Ninety One UK Ltd now owns 1,119,132 shares of the company’s stock valued at $163,751,000 after buying an additional 183,686 shares in the last quarter. Quilter Plc boosted its position in Zoetis by 10.2% in the third quarter. Quilter Plc now owns 438,959 shares of the company’s stock valued at $64,228,000 after buying an additional 40,615 shares in the last quarter. Finally, Swedbank AB grew its stake in shares of Zoetis by 60.4% during the third quarter. Swedbank AB now owns 2,436,888 shares of the company’s stock worth $356,565,000 after buying an additional 917,598 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on ZTS. Morgan Stanley set a $160.00 price target on shares of Zoetis in a report on Thursday, December 18th. The Goldman Sachs Group upgraded Zoetis to a “buy” rating in a research report on Monday, December 15th. Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a report on Saturday, February 21st. BTIG Research reissued a “buy” rating and set a $160.00 price target on shares of Zoetis in a research note on Thursday, February 26th. Finally, Stifel Nicolaus reduced their price target on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Tuesday, November 18th. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Zoetis presently has a consensus rating of “Hold” and an average price target of $152.91.

Zoetis Stock Performance

NYSE ZTS opened at $122.29 on Tuesday. The company has a market capitalization of $51.62 billion, a price-to-earnings ratio of 20.31, a PEG ratio of 1.85 and a beta of 0.95. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. Zoetis Inc. has a twelve month low of $115.25 and a twelve month high of $177.00. The stock has a fifty day simple moving average of $125.99 and a 200 day simple moving average of $132.65.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. The firm had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Sell-side analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s dividend payout ratio is presently 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.